Description for Phosphatidylserine (PS) |
Lipid |
Phosphatidylserine (PS) |
Species |
Homo sapiens |
Phosphatidylserine (PS) identified in exosomes derived from the following tissue/cell type |
Ascites [Exosomes]
|
19188015
|
Atherosclerotic plaques [Apoptotic bodies]
|
9918520
|
Dendritic cells [Exosomes]
|
14965343
|
Inflammatory fluid [Microvesicles]
|
7697722
|
Macrophage [Microvesicles/Exosomes]
|
22711894
|
Macrophage [Exosomes]
|
22711894
|
Macrophage [Exosomes]
|
22711894
|
Macrophage [Exosomes]
|
22711894
|
Melanoma cells [Exosomes]
|
19801663
|
Ovarian cancer cells [Exosomes]
|
19188015
|
Ovarian cancer cells [Exosomes]
|
19188015
|
Plasma [Microparticles]
|
12805058
|
Plasma [Microparticles]
|
9396452
|
Plasma [Microparticles]
|
9396452
|
Plasma [Microparticles]
|
12805058
|
Plasma [Microparticles]
|
12196479
|
Plasma [Microparticles]
|
12196479
|
Plasma [Microparticles]
|
12196479
|
Platelets [Microparticles]
|
10233897
|
Platelets [Microparticles]
|
10233897
|
Platelets [Microparticles]
|
10233897
|
Red blood cells [Microvesicles]
|
7697722
|
Synovial fluid [Microvesicles]
|
23185418
|
Experiment description of studies that identified Phosphatidylserine (PS) in exosomes |
1
|
Experiment ID | 131 |
Identified molecule | Lipid
|
Identification method | Cytofluorographic analysis Annexin-V-FITC
|
PubMed ID |
19188015
|
Organism | Homo sapiens |
Experiment description | Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes |
Authors | Keller S, Kö AK, Marmé, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. |
Journal name |
CL
|
Publication year | 2009 |
Sample | Ascites |
Sample name | Malignant ascites - Ovarian cancer |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Cytofluorographic analysis Annexin V-FITC Western blotting FACS |
EV-TRACK |
-
|
|
|
2
|
Experiment ID | 221 |
Identified molecule | Lipid
|
Identification method | Immunoaffinity
|
PubMed ID |
9918520
|
Organism | Homo sapiens |
Experiment description | Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity |
Authors | Mallat Z, Hugel B, Ohan J, Lesèe G, Freyssinet JM, Tedgui A |
Journal name |
Circulation
|
Publication year | 1999 |
Sample | Atherosclerotic plaques |
Sample name | Atherosclerotic plaques |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Immunohistochemistry Immunoaffinity |
EV-TRACK |
-
|
|
|
3
|
Experiment ID | 128 |
Identified molecule | Lipid
|
Identification method | HPLC Gas chromatography
|
PubMed ID |
14965343
|
Organism | Homo sapiens |
Experiment description | Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization |
Authors | Laulagnier K, Motta C, Hamdi S, Roy S, Fauvelle F, Pageaux JF, Kobayashi T, Salles JP, Perret B, Bonnerot C, Record M. |
Journal name |
BJ
|
Publication year | 2004 |
Sample | Dendritic cells |
Sample name | Bone marrow - Dendritic cells |
Molecules identified in the study | Lipids |
Methods used in the study | High performance liquid chromatography Gas chromatography |
EV-TRACK |
-
|
|
|
4
|
Experiment ID | 233 |
Identified molecule | Lipid
|
Identification method | Thin layer chromatography Cytofluorographic analysis
|
PubMed ID |
7697722
|
Organism | Homo sapiens |
Experiment description | Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells |
Authors | Fourcade O, Simon MF, Viodé, Rugani N, Leballe F, Ragab A, Fournié, Sarda L, Chap H |
Journal name |
Cell
|
Publication year | 1995 |
Sample | Inflammatory fluid |
Sample name | Inflammatory fluids - Arthritis |
Molecules identified in the study | Lipids |
Methods used in the study | Thin layer chromatography Cytofluorographic analysis |
EV-TRACK |
-
|
|
|
5
|
Experiment ID | 1012 |
Identified molecule | Lipid
|
Identification method | Mass spectrometry
|
PubMed ID |
22711894
|
Organism | Homo sapiens |
Experiment description | Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. |
Authors | Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. |
Journal name |
J Immunol.
|
Publication year | 2012 |
Sample | Macrophage |
Sample name | Monocyte-derived macrophages - uninfected |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120137: EV-METRIC:17%, 0%
|
|
|
6
|
Experiment ID | 1013 |
Identified molecule | Lipid
|
Identification method | Mass spectrometry
|
PubMed ID |
22711894
|
Organism | Homo sapiens |
Experiment description | Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. |
Authors | Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. |
Journal name |
J Immunol.
|
Publication year | 2012 |
Sample | Macrophage |
Sample name | Monocyte-derived macrophages - HLA-DR pulldwon microvesicles |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120137: EV-METRIC:17%, 0%
|
|
|
7
|
Experiment ID | 1014 |
Identified molecule | Lipid
|
Identification method | Mass spectrometry
|
PubMed ID |
22711894
|
Organism | Homo sapiens |
Experiment description | Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. |
Authors | Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. |
Journal name |
J Immunol.
|
Publication year | 2012 |
Sample | Macrophage |
Sample name | Monocyte-derived macrophages - CHMP4/TSG101 pulldown exosomes |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120137: EV-METRIC:17%, 0%
|
|
|
8
|
Experiment ID | 1015 |
Identified molecule | Lipid
|
Identification method | Mass spectrometry
|
PubMed ID |
22711894
|
Organism | Homo sapiens |
Experiment description | Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. |
Authors | Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. |
Journal name |
J Immunol.
|
Publication year | 2012 |
Sample | Macrophage |
Sample name | Monocyte-derived macrophages - Myosin B pulldown exosomes |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120137: EV-METRIC:17%, 0%
|
|
|
9
|
Experiment ID | 71 |
Identified molecule | Lipid
|
Identification method | Thin layer chromatography
|
PubMed ID |
19801663
|
Organism | Homo sapiens |
Experiment description | Microenvironmental pH is a key factor for exosome traffic in tumor cells. |
Authors | Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, de Milito A, Coscia C, Iessi E, Logozzi MA, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S |
Journal name |
JBC
|
Publication year | 2009 |
Sample | Melanoma cells |
Sample name | Mel1 |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Western blotting Thin layer chromatography |
EV-TRACK |
-
|
|
|
10
|
Experiment ID | 132 |
Identified molecule | Lipid
|
Identification method | Cytofluorographic analysis Annexin-V-FITC
|
PubMed ID |
19188015
|
Organism | Homo sapiens |
Experiment description | Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes |
Authors | Keller S, Kö AK, Marmé, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. |
Journal name |
CL
|
Publication year | 2009 |
Sample | Ovarian cancer cells |
Sample name | OVMz |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Cytofluorographic analysis Annexin V-FITC FACS |
EV-TRACK |
-
|
|
|
11
|
Experiment ID | 133 |
Identified molecule | Lipid
|
Identification method | Cytofluorographic analysis Annexin-V-FITC
|
PubMed ID |
19188015
|
Organism | Homo sapiens |
Experiment description | Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes |
Authors | Keller S, Kö AK, Marmé, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. |
Journal name |
CL
|
Publication year | 2009 |
Sample | Ovarian cancer cells |
Sample name | SKOV3ip |
Molecules identified in the study | Protein Lipids |
Methods used in the study | Cytofluorographic analysis Annexin V-FITC FACS |
EV-TRACK |
-
|
|
|
12
|
Experiment ID | 261 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
12805058
|
Organism | Homo sapiens |
Experiment description | Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes |
Authors | Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. |
Journal name |
Blood
|
Publication year | 2003 |
Sample | Plasma |
Sample name | Plasma - Sickle cell patients - Crisis |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
13
|
Experiment ID | 250 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
9396452
|
Organism | Homo sapiens |
Experiment description | Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant |
Authors | Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A |
Journal name |
Circulation
|
Publication year | 1997 |
Sample | Plasma |
Sample name | Plasma - Systemic blood - Cardiopulmonary bypass patients |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
14
|
Experiment ID | 251 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
9396452
|
Organism | Homo sapiens |
Experiment description | Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant |
Authors | Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A |
Journal name |
Circulation
|
Publication year | 1997 |
Sample | Plasma |
Sample name | Plasma - Pericardial blood - Cardiopulmonary bypass patients |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
15
|
Experiment ID | 262 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
12805058
|
Organism | Homo sapiens |
Experiment description | Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes |
Authors | Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. |
Journal name |
Blood
|
Publication year | 2003 |
Sample | Plasma |
Sample name | Plasma - Sickle cell patients - Steady state |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
16
|
Experiment ID | 288 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
12196479
|
Organism | Homo sapiens |
Experiment description | Type 1 and type 2 diabetic patients display different patterns of cellular microparticles |
Authors | Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F |
Journal name |
Diabetes
|
Publication year | 2002 |
Sample | Plasma |
Sample name | Plasma - Healthy donors |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
17
|
Experiment ID | 289 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
12196479
|
Organism | Homo sapiens |
Experiment description | Type 1 and type 2 diabetic patients display different patterns of cellular microparticles |
Authors | Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F |
Journal name |
Diabetes
|
Publication year | 2002 |
Sample | Plasma |
Sample name | Plasma - Type 1 diabetes |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
18
|
Experiment ID | 290 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
12196479
|
Organism | Homo sapiens |
Experiment description | Type 1 and type 2 diabetic patients display different patterns of cellular microparticles |
Authors | Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F |
Journal name |
Diabetes
|
Publication year | 2002 |
Sample | Plasma |
Sample name | Plasma - Type 2 diabetes |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS Annexin V-FITC |
EV-TRACK |
-
|
|
|
19
|
Experiment ID | 278 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
10233897
|
Organism | Homo sapiens |
Experiment description | Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia |
Authors | Hugel B, Socié, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML |
Journal name |
Blood
|
Publication year | 1999 |
Sample | Platelets |
Sample name | Platelets - Normal |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS |
EV-TRACK |
-
|
|
|
20
|
Experiment ID | 240 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
10233897
|
Organism | Homo sapiens |
Experiment description | Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia |
Authors | Hugel B, Socié, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML |
Journal name |
Blood
|
Publication year | 1999 |
Sample | Platelets |
Sample name | Platelets - Paroxysmal nocturnal hemoglobinuria patients |
Molecules identified in the study | Protein Lipids |
Methods used in the study | FACS |
EV-TRACK |
-
|
|
|
21
|
Experiment ID | 295 |
Identified molecule | Lipid
|
Identification method | Annexin V-FITC
|
PubMed ID |
10233897
|
Organism | Homo sapiens |
Experiment description | Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia |
Authors | Hugel B, Socié, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML |
Journal name |
Blood
|
Publication year | 1999 |
Sample | Platelets |
Sample name | Platelets - Aplastic anemia patients |
Molecules identified in the study | Lipids |
Methods used in the study | FACS |
EV-TRACK |
-
|
|
|
22
|
Experiment ID | 232 |
Identified molecule | Lipid
|
Identification method | Thin layer chromatography Cytofluorographic analysis
|
PubMed ID |
7697722
|
Organism | Homo sapiens |
Experiment description | Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells |
Authors | Fourcade O, Simon MF, Viodé, Rugani N, Leballe F, Ragab A, Fournié, Sarda L, Chap H |
Journal name |
Cell
|
Publication year | 1995 |
Sample | Red blood cells |
Sample name | Erythrocyte |
Molecules identified in the study | Lipids |
Methods used in the study | Thin layer chromatography Cytofluorographic analysis |
EV-TRACK |
-
|
|
|
23
|
Experiment ID | 1011 |
Identified molecule | Lipid
|
Identification method | Mass spectrometry
|
PubMed ID |
23185418
|
Organism | Homo sapiens |
Experiment description | Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. |
Authors | Gyö B, Szabó, TuriáL, Wright M, Herczeg P, Léczi Z, Kittel A, PolgáA, TóK, Déalvi B, ZelenáG, Böz I, Carr B, Nagy G, Véy K, Gay S, Falus A, BuzáEI. |
Journal name |
PLoS One.
|
Publication year | 2012 |
Sample | Synovial fluid |
Sample name | synovial fluid - patient with juvenile idiopathic arthritis (JIA) |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry FACS |
EV-TRACK |
EV120104: EV-METRIC:29%
|
|
|